Valbenazine Shines in Open-Label Extension, FDA Grants Breakthrough Designation to NfL Test, Tocilizumab Effective in NMOSD
Neurology News Network for the week ending November 18, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — November 17, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 17, 2023.
This Week on NeurologyLive® — November 13, 2023
Here's some of what is coming soon to NeurologyLive® this week.
FDA Clears Modius Sleep Device, NDA Accepted for SPN-830, Zilucoplan Improves Myasthenic Fatigue
Neurology News Network for the week ending November 11, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — November 10, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 10, 2023.
This Week on NeurologyLive® — November 6, 2023
Migraine Preventive Prescription Trends, TAK-861 Phase 1 Study in Narcolepsy, Simufilam Not Associated With ARIA-E
Neurology News Network for the week ending November 4, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — November 3, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 3, 2023.
This Week on NeurologyLive® — October 30, 2023
FDA Approves Vamorolone for DMD, Tau Agent BIIB080 Shows Promising Results, Subcutaneous Lecanemab More Effective in Amyloid Removal
Neurology News Network for the week ending October 28, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — October 27, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 27, 2023.
This Week on NeurologyLive® — October 23, 2023
Solanezumab Fails A4 Alzheimer Study, FDA Lifts Hold on FREEDOM-DM1 Trial, CMS Announces Coverages of PET Amyloid-ß Imaging
Neurology News Network for the week ending October 21, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — October 20, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 20, 2023.
This Week on NeurologyLive® — October 16 2023
FDA Hands CRL to Patisiran, GBA1 Parkinson Trial Initiated, Levetiracetam Effective as First-Line Treatment in IGE Syndromes
Neurology News Network for the week ending October 14, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — October 13, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 13, 2023.
This Week on NeurologyLive® — October 9 2023
FDA Clears High Dose Cohort of CTI-1601, SOMNUM AI Device Approved, Intracranial Pressure Monitoring and TBI
Neurology News Network for the week ending October 7, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — October 6, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 6, 2023.
This Week on NeurologyLive® — October 2, 2023
AdComm Committee Downvotes NurOwn, ADELY01 Cleared for Trials, Axsome Pushes Back SYMPHONY Trial
Neurology News Network for the week ending September 30, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — September 29, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 29, 2023.
This Week on NeurologyLive® — September 25, 2023
FDA Approves AIRAscore, Pimavanserin Packing Label Updated, Blarcamesine Data Released
Neurology News Network for the week ending September 23, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — September 22, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 22, 2023.
This Week on NeurologyLive® — September 18, 2023
MS Treatments Linked With PML, Neflamapimod Effectiveness Based on P-Tau181 Levels, Nerivio Safe in Pregnant Women
Neurology News Network for the week ending September 16, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — September 15, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 15, 2023.
This Week on NeurologyLive® — September 11, 2023